Frontiers in Immunology, 2025 · DOI: 10.3389/fimmu.2024.1483402 · Published: January 15, 2025
This study investigates how spinal cord injury (SCI) affects lung inflammation and immune responses after exposure to lipopolysaccharide (LPS), a substance that mimics bacterial infection. It focuses on SCI at the T9 level in mice. The research found that SCI significantly increases lung inflammation and the release of inflammatory substances called cytokines in response to LPS exposure. This suggests that SCI can worsen lung-related complications, like pneumonia. The study also showed that bone marrow-derived macrophages (BMDMs) from mice with SCI are more responsive to LPS, indicating that SCI can affect the behavior of immune cells and contribute to heightened inflammation in the lungs.
The study suggests potential therapeutic targets for managing respiratory complications in individuals with SCI, focusing on modulating the inflammatory response.
Findings contribute to better risk stratification for SCI patients regarding susceptibility to lung injury and infections.
Level-specific responses after SCI indicate that tailored SCI subtype-specific therapeutic interventions may be warranted